foto

C.L. de Groot-Eckhardt MD PhD

Positions
Other Academic Staff, Medical Specialist
Main activities
Patient care
Specialisation
Resident (AGIKO), Pediatrics, Emma Children's Hospital, Amsterdam
Focus of research

Hemophilia, pediatric hematology, bleeding disorders

Key publications
  • Eckhardt Corien L., van Velzen Alice S., Peters Marjolein, Astermark Jan, Brons Paul P., Castaman Giancarlo, Cnossen Marjon H., Dors Natasja, Escuriola-Ettingshausen Carmen, Hamulyak Karly, Hart Daniel P., Hay Charles R. M., Haya Saturnino, van Heerde Waander L., Hermans Cedric, Holmström Margareta, Jimenez-Yuste Victor, Keenan Russell D., Klamroth Robert, Laros-van Gorkom Britta A. P., Leebeek Frank W. G., Liesner Ri, Mäkipernaa Anne, Male Christoph, Mauser-Bunschoten Evelien, Mazzucconi Maria G., McRae Simon, Meijer Karina, Mitchell Michael, Morfini Massimo, Nijziel Marten, Oldenburg Johannes, Peerlinck Kathelijne, Petrini Pia, Platokouki Helena, Reitter-Pfoertner Sylvia E., Santagostino Elena, Schinco Piercarla, Smiers Frans J., Siegmund Berthold, Tagliaferri Annarita, Yee Thynn T., Kamphuisen Pieter Willem, van der Bom Johanna G., Fijnvandraat Karin Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A Blood 2013;122 (11):1954-1962 [PubMed]
  • Eckhardt C. L., Loomans J. I., van Velzen A. S., Peters M., Mauser-Bunschoten E. P., Schwaab R., Mazzucconi M. G., Tagliaferri A., Siegmund B., Reitter-Pfoertner S. E., van der Bom J. G., Fijnvandraat K., Kamphuisen P. W., Peerlinck K., Oldenburg J., Santagostino E., Astermark J., Streefkerk N., Loomans J. L., van Eijkelenburg A., Jansen A. J., Kruijt C. C., van Tienoven B., van Baar A. C. G., Corten I. W., Meijer K., Nijziel M. R., Dors N., Hamulyak K., Beckers E., Brons P. P., Laros-van Gorkom B. A. P., van Heerde W. L., Leebeek F., Kruip M., Cnossen M. H., Mauser-Bunschoten E., Fischer K., Smiers F. J., Hermans C., Klamroth R., Escuriola-Ettingshausen C., Königs C., Petrini P., Holmström M., Mäkipernaa A., Male C., Pabinger I., Keenan R. D., Liesner R. Inhibitor development and mortality in non-severe hemophilia A Journal of thrombosis and haemostasis 2015;13 (7):1217-1225 [PubMed]
  • Eckhardt C. L., van der Bom J. G., van der Naald M., Peters M., Kamphuisen P. W., Fijnvandraat K. Surgery and inhibitor development in hemophilia A: a systematic review Journal of thrombosis and haemostasis 2011;9 (10):1948-1958 [PubMed]
  • Eckhardt C. L., Menke L. A., van Ommen C. H., van der Lee J. H., Geskus R. B., Kamphuisen P. W., Peters M., Fijnvandraat K. Intensive peri-operative use of factor VIII and the Arg593-->Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A Journal of thrombosis and haemostasis 2009;7 (6):930-937 [PubMed]
  • Eckhardt C. L., Astermark J., Nagelkerke S. Q., Geissler J., Tanck M. W. T., Peters M., Fijnvandraat K., Kuijpers T. W. The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A Journal of thrombosis and haemostasis 2014;12 (8):1294-1301 [PubMed]
All Publications
Research programmes

Prof. C.J. Fijnvandraat PhD (Etiology of inhibitor development in hemophilia & Alloimunisation in Sickle Cell Disease)